Otsuka (OTCMKTS:OTSKY) Releases Quarterly Earnings Results, Beats Expectations By $0.19 EPS

Otsuka (OTCMKTS:OTSKY) released its earnings results on Friday. The company reported $0.70 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.51 by $0.19, Zacks reports. The company had revenue of $4.41 billion for the quarter, compared to the consensus estimate of $3.95 billion. Otsuka had a net margin of 15.01% and a return on equity of 12.33%. Otsuka updated its FY 2026 guidance to 2.119-2.119 EPS.

Otsuka Stock Performance

Shares of OTSKY opened at $34.41 on Friday. The company has a debt-to-equity ratio of 0.05, a current ratio of 2.17 and a quick ratio of 1.67. The stock has a 50-day moving average of $34.15 and a 200-day moving average of $33.52. The company has a market cap of $36.96 billion and a PE ratio of 14.52. Otsuka has a one year low of $23.67 and a one year high of $37.52.

About Otsuka

Otsuka Pharmaceutical Co, Ltd., trading in the U.S. under the ticker OTCMKTS:OTSKY, is a global healthcare company headquartered in Tokyo, Japan. The firm’s core activities span the development, manufacturing and marketing of prescription pharmaceuticals, consumer healthcare products and nutraceuticals. Otsuka focuses its research on areas such as neuroscience, cardiovascular and renal therapies, and oncology, aiming to bring innovative treatments to patients worldwide.

Founded in 1964 by Busaburo Otsuka as a subsidiary of the Otsuka Group, the company has grown into a diversified healthcare enterprise over more than five decades.